TY - JOUR AU - Ploeg, M. AU - Aben, K. K. AU - Kiemeney, L. A. PY - 2009 DA - 2009// TI - The present and future burden of urinary bladder cancer in the world JO - World J Urol VL - 27 UR - https://doi.org/10.1007/s00345-009-0383-3 DO - 10.1007/s00345-009-0383-3 ID - Ploeg2009 ER - TY - JOUR AU - Ferlay, J. AU - Shin, H. R. AU - Bray, F. AU - Forman, D. AU - Mathers, C. AU - Parkin, D. M. PY - 2010 DA - 2010// TI - Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25516 DO - 10.1002/ijc.25516 ID - Ferlay2010 ER - TY - STD TI - Howlader N, Noone, AM, Krapcho M. SEER Cancer Statistics Review 1975–2010. National Cancer Institute, Bethesda, MD, USA. 2012. ID - ref3 ER - TY - JOUR AU - Young, R. H. PY - 1997 DA - 1997// TI - Pseudoneoplastic lesions of the urinary bladder and urethra: a selective review with emphasis on recent information JO - Semin Diagn Pathol VL - 14 ID - Young1997 ER - TY - JOUR AU - Dabrowska, A. AU - Slotwinski, R. AU - Kedziora, S. PY - 2012 DA - 2012// TI - Inflammation and cancer-double face of Toll-like receptors JO - Centr Eur J Immunol VL - 37 ID - Dabrowska2012 ER - TY - STD TI - Kim R, Liu W, Chen X, Kreder KJ, Luo Y. Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. Journal of Biomedicine and Biotechnology. J Biomed Biotechnol. 2011:937061. ID - ref6 ER - TY - JOUR AU - Kolls, J. K. AU - Linden, A. PY - 2004 DA - 2004// TI - Interleukin-17 family members and inflammation JO - Immunity VL - 21 UR - https://doi.org/10.1016/j.immuni.2004.08.018 DO - 10.1016/j.immuni.2004.08.018 ID - Kolls2004 ER - TY - JOUR AU - Chang, S. H. AU - Dong, C. PY - 2007 DA - 2007// TI - A novel heterodimeric cytokine consisting of IL-17 and IL-17 F regulates inflammatory responses JO - Cell Res VL - 17 ID - Chang2007 ER - TY - JOUR AU - Pappu, R. AU - Ramirez-Carrozzi, V. AU - Sambandam, A. PY - 2011 DA - 2011// TI - The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases JO - Immunology VL - 134 UR - https://doi.org/10.1111/j.1365-2567.2011.03465.x DO - 10.1111/j.1365-2567.2011.03465.x ID - Pappu2011 ER - TY - JOUR AU - Angulo, A. AU - Faris, R. AU - Daniel, B. AU - Jolly, C. AU - Graffenried, L. PY - 2015 DA - 2015// TI - Age-related increase in IL-17 activates pro-inflammatory signaling in prostate cells JO - Prostate VL - 75 UR - https://doi.org/10.1002/pros.22931 DO - 10.1002/pros.22931 ID - Angulo2015 ER - TY - JOUR AU - Song, X. AU - Qian, Y. PY - 2013 DA - 2013// TI - IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases JO - Cell Signal VL - 25 UR - https://doi.org/10.1016/j.cellsig.2013.07.021 DO - 10.1016/j.cellsig.2013.07.021 ID - Song2013 ER - TY - JOUR AU - Divekar, R. AU - Kita, H. PY - 2015 DA - 2015// TI - Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation JO - Curr Opin Allergy Clin Immunol VL - 15 UR - https://doi.org/10.1097/ACI.0000000000000133 DO - 10.1097/ACI.0000000000000133 ID - Divekar2015 ER - TY - JOUR AU - Benatar, T. AU - Cao, M. Y. AU - Lee, Y. AU - Li, H. AU - Feng, N. AU - Gu, X. PY - 2008 DA - 2008// TI - Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors JO - Cancer Immunol Immunother VL - 57 UR - https://doi.org/10.1007/s00262-008-0502-9 DO - 10.1007/s00262-008-0502-9 ID - Benatar2008 ER - TY - JOUR AU - Lamagna, C. AU - Aurrand-Lions, M. AU - Imhof, B. A. PY - 2006 DA - 2006// TI - Dual role of macrophages in tumor growth and angiogenesis JO - J Leukoc Biol VL - 80 UR - https://doi.org/10.1189/jlb.1105656 DO - 10.1189/jlb.1105656 ID - Lamagna2006 ER - TY - JOUR AU - Baharlou, R. AU - Khezri, A. AU - Razmkhah, M. AU - Habibagahi, M. AU - Hosseini, A. AU - Ghaderi, A. PY - 2015 DA - 2015// TI - Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer JO - Iran Red Crescent Med J VL - 17 UR - https://doi.org/10.5812/ircmj.9244 DO - 10.5812/ircmj.9244 ID - Baharlou2015 ER - TY - JOUR AU - Doroudchi, M. AU - Saidi, M. AU - Malekzadeh, M. AU - Golmoghaddam, H. AU - Khezri, A. AU - Ghaderi, A. PY - 2013 DA - 2013// TI - Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status JO - Future Oncol VL - 9 UR - https://doi.org/10.2217/fon.12.180 DO - 10.2217/fon.12.180 ID - Doroudchi2013 ER - TY - JOUR AU - Wang, L. AU - Yi, T. AU - Kortylewski, M. AU - Pardoll, D. M. AU - Zeng, D. AU - Yu, H. PY - 2009 DA - 2009// TI - IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway JO - J Exp Med VL - 206 UR - https://doi.org/10.1084/jem.20090207 DO - 10.1084/jem.20090207 ID - Wang2009 ER - TY - JOUR AU - Takeuchi, A. AU - Dejima, T. AU - Hisakata Shibata, K. AU - Nakamura, R. AU - Eto, M. PY - 2011 DA - 2011// TI - IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovisbacillus Calmette-Guérin treatment against bladder cancer JO - Eur J Immunol VL - 41 UR - https://doi.org/10.1002/eji.201040773 DO - 10.1002/eji.201040773 ID - Takeuchi2011 ER - TY - JOUR AU - Liu, Y. AU - Zhao, X. AU - Sun, X. AU - Li, Y. AU - Wang, Z. AU - Jiang, J. PY - 2015 DA - 2015// TI - Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia JO - Prostate VL - 75 UR - https://doi.org/10.1002/pros.23058 DO - 10.1002/pros.23058 ID - Liu2015 ER - TY - JOUR AU - Robertson, A. J. AU - Beck, J. S. AU - Burnett, R. A. AU - Howatson, S. R. AU - Lee, F. D. AU - Lessells, A. M. PY - 1990 DA - 1990// TI - Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders JO - J Clin Pathol VL - 43 UR - https://doi.org/10.1136/jcp.43.1.17 DO - 10.1136/jcp.43.1.17 ID - Robertson1990 ER - TY - JOUR AU - Hanno, P. M. PY - 1999 DA - 1999// TI - The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health interstitial cystitis database study JO - J Urol VL - 161 UR - https://doi.org/10.1016/S0022-5347(01)61948-7 DO - 10.1016/S0022-5347(01)61948-7 ID - Hanno1999 ER - TY - JOUR AU - Baharlou, R. AU - Ahmadi Vasmehjani, A. AU - Dehghani, A. AU - Ghobadifar, M. A. AU - Khoubyari, M. PY - 2014 DA - 2014// TI - Reduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancer JO - Immune Netw VL - 14 UR - https://doi.org/10.4110/in.2014.14.3.156 DO - 10.4110/in.2014.14.3.156 ID - Baharlou2014 ER - TY - JOUR AU - Logadottir, Y. AU - Delbro, D. AU - Fall, M. AU - Gjertsson, I. AU - Jirholt, P. AU - Lindholm, C. PY - 2014 DA - 2014// TI - Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C JO - J Urol VL - 192 UR - https://doi.org/10.1016/j.juro.2014.04.099 DO - 10.1016/j.juro.2014.04.099 ID - Logadottir2014 ER - TY - STD TI - Rasoul B, Abbas AV, Ali D, Mohamed AG, Mahshid K. Reduced Interleukin-17 and Transforming Growth Factor Beta Levels in Peripheral Blood as Indicators for Following the Course of Bladder Cancer. Immune Netw. 2014;14:156–63. ID - ref24 ER - TY - STD TI - Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. The Journal of Experimental Medicine. 2009;206:1457–64. ID - ref25 ER - TY - JOUR AU - Boltjes, A. AU - Wijk, F. PY - 2014 DA - 2014// TI - Human dendritic cell functional specialization in steady-state and inflammation JO - Front Immunol VL - 5 UR - https://doi.org/10.3389/fimmu.2014.00131 DO - 10.3389/fimmu.2014.00131 ID - Boltjes2014 ER - TY - JOUR AU - Starnes, T. AU - Robertson, M. J. AU - Sledge, G. AU - Kelich, S. AU - Nakshatri, H. AU - Broxmeyer, H. E. PY - 2001 DA - 2001// TI - Cutting edge: IL-17 F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production JO - J imunol VL - 167 UR - https://doi.org/10.4049/jimmunol.167.8.4137 DO - 10.4049/jimmunol.167.8.4137 ID - Starnes2001 ER - TY - JOUR AU - Takahashi, H. AU - Numasaki, M. AU - Lotze, M. T. AU - Sasaki, H. PY - 2005 DA - 2005// TI - Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells JO - Immunol Lett VL - 98 UR - https://doi.org/10.1016/j.imlet.2004.11.012 DO - 10.1016/j.imlet.2004.11.012 ID - Takahashi2005 ER - TY - JOUR AU - Numasaki, M. AU - Fukushi, J. AU - Ono, M. AU - Narula, S. K. AU - Zavodny, P. J. AU - Kudo, T. PY - 2003 DA - 2003// TI - Interleukin-17 promotes angiogenesis and tumor growth JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-05-1461 DO - 10.1182/blood-2002-05-1461 ID - Numasaki2003 ER - TY - JOUR AU - Ruffell, B. AU - Coussens, L. M. PY - 2015 DA - 2015// TI - Macrophages and therapeutic resistance in cancer JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.02.015 DO - 10.1016/j.ccell.2015.02.015 ID - Ruffell2015 ER -